Construction and Practice of Integrated Pharmaceutical Care System of “Internet+Medical Consortium ”
- VernacularTitle:“互联网+医联体”一体化药学服务体系的构建及实践
- Author:
Suxin WAN
1
;
Wei FANG
1
;
Qiuyan SUN
1
Author Information
1. Dept. of Pharmacy，Chongqing Three Gorges Central Hospital，Chongqing 404000，China
- Publication Type:Journal Article
- Keywords:
Internet;
Medical consortium;
Integration;
Pharmaceutical care system;
Construction;
Practice
- From:
China Pharmacy
2019;30(23):3199-3204
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE： To achieve the homogenization of pharmaceutical care in medical consortium and improve the capacity of pharmaceutical care in the region. METHODS： Medical consortium should be established， and then integrated pharmaceutical care system should be constructed； key points， entry points and effects of the system were introduced. RESULTS： Taking Chongqing Three Gorges Central Hospital as the center， “1+4+30” integrated pharmaceutical care system （which means “1 center， 4 medical communities and 30 medical consortium”） has been established. The system included four key points， such as the integration of supply and management system （the connection of supply catalogue， the integration of drug evaluation）， the standardization of pharmaceutical care （the establishment of pharmaceutical care standards or norms in medical consortium， the establishment and implementation of unified pharmacy service standards， the establishment of outpatient pharmaceutical care standards in drug treatment management）， the integration of personnel training and the sharing of information in the system； one breakthrough point which was “Internet+medical consortium” chronic disease drug treatment whole process management （including offline and online framework， hospital and out of hospital service process， the establishment of chronic disease drug management platform）. The establishment of this system could bring four effects， such as obvious benefits to patients， improvement of the pharmaceutical care ability in basic medical institutions， improvement of pharmaceutical care ability of leading units， accumulation of scientific research data. CONCLUSIONS： “1+4+30” integrated pharmaceutical care system realizes the homogeneity of management and service level within the system， realizes the whole process management of drug treatment for patients with chronic diseases， and constructs a new pharmaceutical care mode that is beneficial to patients， grass-roots units and leading units.
